Solana Company

NASDAQ:HSDT

Medical - Devices

Healthcare
$1.63 +0.63%

+$0.01 today

Market cap
$95.17M
Beta
1.03
P/E (TTM)
-0.9
EPS (TTM)
-$1.78
52W Low $1.19High $25.50

Volume 0.23M

Average 0.38M

HSDT EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Solana CompanyNASDAQ: HSDT

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA remains negative

Q1 FY2026 EBITDA was -$99.8M, compared with -$3.83M a year earlier. Trailing-twelve-month EBITDA was -$135.55M.

Context

  • EBITDA amounted to 657.7% of revenue in FY2025, down 1996.7 pp from a year earlier.
  • EBITDA grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of -$14.97M (+62.2%) for the fiscal year ending Dec 2026, a step up from the -186.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$99.8M-130.7% QoQ
Last fiscal yearDec 2025
-$39.58M-186.7% YoY
LTMMar 2026
-$135.55M-1012.4% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2505.7%+88.3%+2594.0 pp
1 year-186.7%+62.2%+248.9 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
(39.58M) USD
Year-over-year change
-186.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How HSDT compares with its peers on the latest reported figures

  • HSDT's LTM Mar 2026 EBITDA of -$135.55M is the lowest of the 11 companies compared; the peer median is -$29.4M.
  • Its year-over-year change of -1012.4% is the lowest of 11, against a peer median of +15.1%.
  • EBITDA amounts to 1413.6% of revenue for HSDT, versus a peer median of 52.1%.
HSDT Competitors Peer median
EBITDA for HSDT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INFUInfuSystem Holdings, Inc.LTM Mar 2026$25.86M +21.2%+19.2%18.2%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$22.67M +217.1%+59.4%51.1%
ELMDElectromed, Inc.LTM Mar 2026$14.78M +39.5%+46.7%20.6%
INGNInogen, Inc.LTM Mar 2026-$5.23M +26.2%—1.5%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026-$20.95M +5.5%—46.7%
PROFProfound Medical Corp.LTM Mar 2026-$37.85M +9.1%—200.6%
NNOXNano-X Imaging Ltd.LTM Dec 2025-$49M -11.0%—376.3%
OMOutset Medical, Inc.LTM Mar 2026-$62.35M +22.0%—53.0%
QTRXQuanterix CorporationLTM Mar 2026-$84.67M -104.0%—58.4%
CATXPerspective Therapeutics, Inc.LTM Mar 2026-$110.64M -31.7%—17902.8%
HSDTSolana CompanyLTM Mar 2026-$135.55M -1012.4%—1413.6%
Peer median (excluding HSDT) -$29.4M+15.1%+46.7%52.1%

Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue522K787K644K520K6.02M
Cost of Revenue298K463K583K582K500K
Gross Profit224K324K61K(62K)5.52M
Gross Margin42.9%41.2%9.5%-11.9%91.7%
Research & Development5.99M4.26M2.94M3.66M3.51M
Selling, General & Admin12.18M10.64M9.27M10.12M23.13M
Operating Expenses18.37M15.84M12.49M13.84M26.64M
Depreciation & Amortization312K255K162K60K680K
EBITDA(17.82M)(14.5M)(12.11M)(13.8M)(39.58M)
EBITDA Margin-3413.8%-1842.9%-1880.0%-2654.4%-657.7%
Operating Income(18.14M)(15.52M)(12.43M)(13.9M)(21.12M)
Operating Margin-3475.5%-1971.5%-1929.8%-2673.7%-351.0%
Interest Income00257K00
Interest Expense0834K017K635K
Other Income / Expenses10K1.44M3.58M2.16M(19.77M)
Income Before Tax(18.13M)(14.07M)(8.85M)(11.74M)(40.89M)
Pre-Tax Margin-3473.6%-1788.1%-1374.2%-2258.1%-679.6%
Income Tax Expense00000
Net Income(18.13M)(14.07M)(8.85M)(11.74M)(40.89M)
Net Margin-3473.6%-1788.1%-1374.2%-2258.1%-679.6%
EPS (Basic)(184.51)(26.06)(7.28)(4.33)(1.85)
EPS (Diluted)(184.51)(26.06)(7.28)(4.33)(1.85)
Weighted Avg Shares98.27K539.89K1.22M2.71M22.05M
Weighted Avg Shares (Diluted)98.27K539.89K1.22M2.71M22.05M

Solana Company

NASDAQ:HSDT

Intrinsic Alpha fair value

Locked

Current Price

$1.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.